CINECA IRIS Institutional Research Information System

PIRRO, Elisa
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.999
EU - Europa 1.751
AS - Asia 778
SA - Sud America 30
OC - Oceania 17
AF - Africa 15
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.591
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.986
IT - Italia 422
CN - Cina 301
DK - Danimarca 239
SG - Singapore 207
SE - Svezia 178
IE - Irlanda 171
FR - Francia 146
DE - Germania 132
UA - Ucraina 97
FI - Finlandia 84
AT - Austria 59
GB - Regno Unito 59
IN - India 58
JP - Giappone 57
KR - Corea 57
PL - Polonia 38
ES - Italia 33
VN - Vietnam 23
BE - Belgio 21
BR - Brasile 17
CZ - Repubblica Ceca 16
AU - Australia 15
TR - Turchia 14
ID - Indonesia 12
CA - Canada 8
CH - Svizzera 8
GR - Grecia 8
HK - Hong Kong 7
NL - Olanda 7
EG - Egitto 6
JO - Giordania 6
RO - Romania 6
CL - Cile 5
IQ - Iraq 5
IR - Iran 5
PK - Pakistan 5
PT - Portogallo 5
RS - Serbia 5
RU - Federazione Russa 5
SN - Senegal 5
TW - Taiwan 5
MX - Messico 4
BG - Bulgaria 3
DZ - Algeria 3
EC - Ecuador 3
MK - Macedonia 3
MY - Malesia 3
TH - Thailandia 3
UZ - Uzbekistan 3
AR - Argentina 2
LT - Lituania 2
NZ - Nuova Zelanda 2
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
BT - Bhutan 1
CO - Colombia 1
CY - Cipro 1
EU - Europa 1
HR - Croazia 1
IL - Israele 1
KG - Kirghizistan 1
LV - Lettonia 1
ME - Montenegro 1
PE - Perù 1
PR - Porto Rico 1
SA - Arabia Saudita 1
SI - Slovenia 1
TN - Tunisia 1
UY - Uruguay 1
Totale 5.591
Salva come PNG Salva come JPEG
Città #
Ann Arbor 529
Chandler 437
Singapore 173
Beijing 171
Dublin 161
Houston 136
Fairfield 131
Torino 104
Ashburn 103
Villeurbanne 94
Nyköping 80
Dearborn 78
Wilmington 74
Jacksonville 70
Woodbridge 67
Princeton 61
Vienna 58
Columbus 54
Medford 54
Santa Clara 53
Redwood City 50
Cambridge 49
Seattle 49
Turin 33
Fremont 32
Pisa 28
New York 27
Warsaw 27
Boston 24
Milan 24
Guangzhou 20
Boardman 17
Dong Ket 16
Munich 16
Brussels 15
Brno 13
Hefei 13
Nanjing 13
Florence 12
Los Angeles 12
San Diego 12
Shanghai 12
Tokyo 11
Jakarta 10
London 10
West Jordan 10
Cork 8
Paris 8
Düsseldorf 7
Mumbai 7
Shenzhen 7
Valencia 7
Würzburg 7
Cuneo 6
Hyderabad 6
Jinan 6
Kunming 6
Nanchang 6
Piemonte 6
São Paulo 6
Bangalore 5
Belgrade 5
Catania 5
Fürstenzell 5
Helsinki 5
Hong Kong 5
Madrid 5
Norwalk 5
Phoenix 5
Rome 5
Taipei 5
Verona 5
Washington 5
Zurich 5
Esslingen am Neckar 4
Falls Church 4
Istanbul 4
Komancza 4
Kumar 4
Nottingham 4
Philadelphia 4
Pune 4
Siena 4
Tianjin 4
Toronto 4
Amman 3
Anghiari 3
Baghdad 3
Bari 3
Bobrowniki Male 3
Boulder 3
Cardenal 3
Copenhagen 3
Dallas 3
Elche 3
Fuzhou 3
Grafing 3
Hamamatsu 3
Heidelberg 3
Islamabad 3
Totale 3.495
Salva come PNG Salva come JPEG
Nome #
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane. 426
A new HPLC-UV validated method for therapeutic drug monitoring of tyrosine kinase inhibitors in leukemic patients. 418
Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children 395
A new HPLC UV validated method for therapeutic monitoring of deferasirox in thalassaemic patients. 201
Deferasirox pharmacokinetic and toxicity correlation in β-thalassaemia major treatment 192
Plasma and Intracellular Imatinib Concentrations in Patients With Chronic Myeloid Leukemia 169
Deferasirox pharmacokinetics evaluation in a woman with hereditary haemochromatosis and heterozygous β-thalassaemia 167
Procedimento cromatografico di dosaggio di DDT, DDD, DDA, e DDE 162
Genetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 159
New hplc-mass spectrometry method for the simultaneous quantification in human plasma of the antileukemia drugs imatinib, dasatinib, and nilotinib 157
Role of Cytochrome P450 in imatinib pharmacokinetics: clinical relevance of inhibitors/inducers concomitant use 155
Pharmacogenetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 144
Preclinical pharmacokinetics comparison between resveratrol 2-hydroxypropyl-β-cyclodextrin complex and resveratrol suspension after oral administration 141
Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection 140
A new simple HPLC method for measuring mitotane and its two principal metabolites Tests in animals and mitotane-treated patients 135
Role of cytochrome P450 in imatinib pharmacokinetics: clinical relevance of inhibitors/inducers concomitant use 134
Short QT syndrome in infancy. Therapeutic drug monitoring of hydroquinidine in a newborn infant. 125
Effect of pharmacogenetic markers of vitamin D pathway on deferasirox pharmacokinetics in children 124
Bioequivalence of Branded and Generic Oxaliplatin: From Preclinical Assessment to Clinical Incidence of Hypersensitivity Reactions 117
Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma 104
Clinical relevance of the assessment of deferasirox trough levels in thalassemia patients 103
Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes 102
Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children 100
Deferasirox pharmacokinetic evaluation in β-thalassaemia paediatric patients 94
Genetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 85
Clinical relevance of deferasirox trough levels in β-thalassemia patients 81
New hplc–uv validated method for therapeutic drug monitoring of antifungal agents in acute myeloid leukemia 80
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane. 79
Role of CYP1A1, ABCG2, CYP24A1 and VDR gene polymorphisms on the evaluation of cardiac iron overload in thalassaemia patients 78
Quantification of imatinib plasma levels in patients with chronic myeloid leukemia: Comparison between HPLC-UV and LC-MS/MS 75
Salicylic acid inhibits dimethylbenzanthracene (DMBA) induced mammary carcinogenesis in a dose dipendent manner 74
Determinanti farmacogenetici della farmacocinetica del mitotane: studio condotto su pazienti affetti da carcinoma corticosurrenalico 74
Influence of single nucleotide polymorphisms on deferasirox Ctrough levels and effectiveness: study on beta-talassemia major affected patients 74
Evaluating the impact of angiogenetic inhibitors on chemical carcinogenesis of oral tumors in the buccal pouch Syrian hamster model 73
Antineoplastic effects of SU5416, a novel vascular endothelial growth factor pathway inhibitor, in an oral cancer model 73
The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients 73
Genetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 71
New HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib, and nilotinib in human plasma 70
EVALUTATION OF THE CONTROL OF PAIN IN PATIENTS WITH BONE METASTASIS UNDERGOING MEDICAL TREATMENT WITH BISPHOSPHONATES 68
Pharmacogenetic of voriconazole antifungal agent in pediatric patients 65
Single nucleotide polymorphisms of ABCB1 gene influence on intracellular concentrations of dasatinib. 64
Salicylate counteracts streptozotocin induced diabetes mellitus in rat 56
Salicylate inhibition of rat mammary carcinogenesis and angiogenesis in female rat compatible with misoprostol administration 55
Pharmacogenetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 51
Pharmacogenetic determinants of mitotane pharmacokinetics in adrenocortical cancer patients 48
New HPLC MS method for the simultaneous quantification in human plasma of the antileukemia drugs imatinib, dasatinib and nilotinib. 46
Pharmacogenetic determinants of imatinib, dasatinib and nilotinib pharmacokinetics in chronic myeloid leukaemia patients 44
Pharmacogenetic determinants of imatinib, dasatinib and nilotinib in chronic myeloid leukaemia patients 37
Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes 33
Evaluation of the control of pain in patients with bone metastasis undergoing medical treatment with bisphosphonates 15
Evaluation of nausea and vomiting in oncology patients treated with chemotherapy: a retrospective study 12
The importance of monitoring circulating mitotane levels in the management of adrenocortical cancer patients 11
VALIDATED MICROBIOLOGICAL ASSAY FOR JOSAMYCIN DETERMINATION IN ITS PHARMACEUTICAL FORMULATIONS 9
Therapeutic drug monitoring: hydroquinidine administration in a newborn infant with short QT syndrome. A case report 8
Totale 5.846
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.824
article - articoli 0
book - libri 0
conference - conferenze 5.973
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.797
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020750 0 0 0 0 78 174 99 49 69 103 78 100
2020/2021613 85 41 35 39 53 49 32 23 73 35 70 78
2021/20221.013 69 65 68 84 53 90 94 65 42 46 192 145
2022/20231.113 114 123 65 124 84 252 53 76 107 29 64 22
2023/2024393 46 59 26 16 27 47 8 22 13 36 34 59
2024/2025436 28 56 46 113 193 0 0 0 0 0 0 0
Totale 5.846